Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]F-AraG PET Imaging in CAR T Cell Therapy for Lymphoma
NCT05096234Phase 1Terminated
- Sponsor
- Stanford University
- Start
- Sep 2021
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial of fluorine f 18 ara-g in non-Hodgkin lymphoma (NHL), sponsored by Stanford University. Primary endpoint: Change in [18F]F-AraG PET signal at Day 4. Started Sep 2021; status: terminated.
02
Drugs
fluorine f 18 ara-g
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT05096234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096234.